RE:Found this on yahoo forumYukonJezza wrote:
supposed letter from Dan to someone inquiring about ate covid drug. I don't believe it though A member of the CEO.CA chat group sent an email to Dan asking about Antibe's participation with COVID trials. Below is what the claimed response from Dan was to this email. "What a great questionthanks!! In fact, we are working in partnership with the Canadian government on Covid with our drugs (not ATB-346), and doing so with despatch. We have had some (very early) promising results and so are continuing this effort. Since it is very early, we do not consider this to be material news; hence why I feel I can tell youif the results continue to be promising, at some point we would say this to the market. Since, however, it is not 346, we would decline to participate in the trial you mention. Thanks again for the great question, Best, Dan
Ya - I'm sure there's some truth to it ... if not all of it.
We know they are running trials with a drug of ours and I would have bet it was 340.
Then again, don't count 352 but that doesn't really make sense to me.
Get the blood thinning quality of Aspirin and the healing effects of H2S - in a safer med ... Bob's your uncle.
The wording is exactly as I'd expect from Dan.
What would really be a treat is 340 revamped in a new molecule (as Dan said they were going to investigate it, and all of a sudden, ended up working on IBD ???? ).
Maybe there is more to the story and they actually did start with a new molecule for 340 first.
I guess we have to wait and see.
It's all about creating value for the family of drugs IMO - leave nothing on the table ... therefore, take as much time as you need to show the value to potential Big Pharma partners.
Fingers crossed.